DAVID ADAMS: Open Payments
NPI 1417443631 · AMMON, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 10 payments from 6 companies in 2025. Trend: 2023 $264 · 2024 $159 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $51 |
| Insulet Corporation | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Alkermes, Inc. | 1 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: Omnipod, COBENFY, VRAYLAR, ARISTADA, FANAPT, INVEGA SUSTENNA, QULIPTA.
Industry payments across ID — which companies pay providers there.
